🚚 Free shipping on all orders above $299 · 30 days money back guarantee · Helpline +1 251-332-4105

Celkeran 5 mg (Chlorambucil)

$105.00$3.50 per tablet · 30 tablets

Celkeran 5 mg Tablet treats blood cancer & Hodgkin’s disease. Order at the best price with fast shipping. Buy online now on PharmeasyBank!

Choose pack sizePrice per tablet shown

Want to order in bulk / B2B price?

Tracked, discreet delivery

Ships in discreet packaging with a tracking number. Free shipping on orders above $299.

30 days money back guarantee

Damaged, missing or only part of your order arrived? Choose a new package or a full refund.

Questions before you order?

Call +1 251-332-4105 or email order@pharmeasybank.com.

SECURE CHECKOUT
DISCOVER
MasterCard
VISA

Share

What Is Celkeran 5 mg?

Celkeran 5 mg (Chlorambucil) is an oral anticancer medicine belonging to the alkylating agent class of chemotherapy drugs.

Chlorambucil is used in the treatment of selected cancers affecting lymphocytes and other cells of the lymphatic and blood-forming systems.

It has established applications in certain types of chronic lymphocytic leukemia and lymphomas.

Chlorambucil works by interfering with the genetic material of cells.

It forms chemical bonds with DNA, leading to DNA damage and cross-linking that interfere with DNA replication and normal cellular division.

Cancer cells that are unable to repair this damage may stop dividing or undergo cell death.

This explains its potential to cause low blood cell counts, infections, anemia and bleeding complications.

How Does Celkeran 5 mg Work?

1. Belongs to the Alkylating Agent Class

Chlorambucil is a nitrogen mustard-derived alkylating chemotherapy medicine.

2. Enters Susceptible Cells

After administration and absorption, chlorambucil reaches cells through systemic circulation.

3. Interacts With Cellular DNA

Chlorambucil forms covalent bonds with DNA components.

The medicine can produce DNA cross-links that interfere with the separation and replication of DNA strands.

5. Disrupts DNA Replication

DNA damage prevents affected cells from copying their genetic material normally.

6. Interferes With Cell Division

Cells with substantial DNA damage may be unable to complete normal cell division.

7. Promotes Cancer Cell Death

Unrepaired DNA damage may activate pathways leading to cell death.

8. Affects Healthy Dividing Cells

Chlorambucil can also damage normal cells, especially bone marrow cells responsible for blood cell production.

Important: Chlorambucil is not selective for cancer cells alone. Its effects on healthy tissues are responsible for many clinically important adverse reactions.

Uses of Celkeran 5 mg

1. Chronic Lymphocytic Leukemia (CLL)

Chlorambucil has historically been used in the treatment of chronic lymphocytic leukemia.

CLL is a cancer involving abnormal accumulation of certain lymphocytes.

Chlorambucil may reduce the number of malignant lymphocytes and help control disease manifestations.

However, modern CLL treatment frequently uses targeted medicines or other regimens, and chlorambucil is not the preferred option for many patients.

2. Hodgkin Lymphoma

Chlorambucil has historical use in certain treatment regimens for Hodgkin lymphoma.

Current treatment generally relies on other established chemotherapy combinations and selected newer therapies.

3. Non-Hodgkin Lymphoma

Chlorambucil has been used for selected non-Hodgkin lymphomas, particularly certain indolent lymphoid malignancies.

Its suitability depends on the lymphoma subtype and treatment guidelines.

4. Follicular Lymphoma

Chlorambucil has historical applications in some follicular lymphoma treatment regimens.

Modern treatment options may include anti-CD20 antibodies, targeted therapies and other systemic treatments.

5. Waldenström Macroglobulinemia

Chlorambucil has been used historically in selected patients with Waldenström macroglobulinemia.

Current treatment selection depends on symptoms, disease characteristics and available therapies.

6. Selected Indolent Lymphoid Malignancies

An oncology specialist may consider chlorambucil in particular circumstances involving slowly progressing lymphoid cancers.

7. Selected Patients Requiring Individualized Therapy

Treatment may be individualized when patient age, frailty, comorbidities, previous treatments or access to alternatives affect the therapeutic decision.

8. Specialist-Directed Oncology Treatment

Chlorambucil may be incorporated into an oncology treatment plan when its expected benefits outweigh its substantial risks.

How to Take Celkeran 5 mg

Celkeran 5 mg must be taken strictly according to the oncology specialist’s prescription.

General Administration Instructions

  1. Confirm the prescribed treatment protocol and tablet strength.
  2. Take the medicine only on the scheduled treatment days.
  3. Follow the oncologist’s instructions regarding food and administration.
  4. Swallow tablets whole unless the manufacturer explicitly instructs otherwise.
  5. Do not crush, split or chew cytotoxic tablets without specialist authorization.
  6. Do not independently increase or decrease the dose.
  7. Attend scheduled blood tests and oncology appointments.
  8. Report fever, unusual bleeding or severe weakness promptly.
  9. Follow the recommended precautions for handling cytotoxic medicines.
  10. Do not stop, restart or repeat treatment without oncology guidance.

Should Celkeran Be Taken With Food?

Food instructions depend on the formulation and treatment protocol.

Some chlorambucil tablet labels recommend administration on an empty stomach.

Follow the specific product label and oncology team’s instructions.

Can Celkeran Tablets Be Crushed?

Chlorambucil is a cytotoxic medicine.

Tablets should generally be swallowed whole and should not be crushed or broken unless the oncology team provides an approved handling method.

What If a Dose Is Missed?

Contact the oncology team for instructions.

Do not take an extra dose or double the next dose.

What If Too Much Celkeran Is Taken?

A chlorambucil overdose can cause serious toxicity, including severe bone marrow suppression and neurological complications.

Seek emergency medical attention or contact a poison control service immediately.

How Long Does Celkeran 5 mg Take to Work?

The clinical response to chlorambucil depends on the malignancy, disease burden, prescribed regimen and patient characteristics.

After Administration

Chlorambucil is absorbed and begins exerting its cytotoxic effects.

During the First Treatment Cycle

The medicine may begin reducing the activity or number of susceptible malignant cells.

Over Several Weeks

Changes in blood counts, lymph node size or other disease markers may become measurable.

During Subsequent Treatment Cycles

The oncology team evaluates treatment response, toxicity and whether the regimen should continue.

Common Side Effects

Possible side effects include:

  • Nausea
  • Vomiting
  • Reduced appetite
  • Diarrhea
  • Mouth irritation
  • Fatigue
  • Weakness
  • Low white blood cell counts
  • Low platelet counts
  • Anemia
  • Increased infection risk
  • Skin rash
  • Menstrual changes
  • Reduced fertility

The frequency and severity of adverse reactions depend on the dose, cumulative exposure, treatment regimen and individual health factors.

Serious Side Effects

Seek urgent medical attention for:

  • Fever or chills
  • Severe or persistent infections
  • Unusual bruising
  • Uncontrolled bleeding
  • Severe weakness or breathlessness
  • Seizures
  • Severe confusion
  • Blistering or peeling skin
  • Severe allergic reactions
  • Persistent cough or breathing difficulties
  • Symptoms of significant anemia

Important Serious Risks

Severe Bone Marrow Suppression: Chlorambucil can substantially reduce white blood cells, red blood cells and platelets.

Serious Infections: Low white blood cell counts can increase the risk of life-threatening infections.

Bleeding Complications: Thrombocytopenia can increase bruising and bleeding risk.

Secondary Malignancies: Chlorambucil is associated with an increased risk of certain secondary cancers, including treatment-related leukemia.

Infertility: Chlorambucil may impair fertility in both males and females. Some effects may be permanent.

Pregnancy Harm: Chlorambucil can harm a developing fetus and should not be used during pregnancy unless a specialist determines that exceptional circumstances justify treatment.

Seizures: Neurological toxicity, including seizures, has been reported.

Severe Skin Reactions: Rare serious reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis, have been reported.

Pulmonary Toxicity: Rare cases of interstitial pulmonary fibrosis and other serious lung complications have been associated with chlorambucil.

Contraindications & Precautions

1. Allergy to Chlorambucil

Patients with known serious hypersensitivity to chlorambucil should not receive the medicine.

2. Previous Resistance to Chlorambucil

Treatment should be reassessed when the disease has demonstrated resistance to chlorambucil.

3. Bone Marrow Suppression

Patients with low blood cell counts require careful assessment because chlorambucil can worsen cytopenias.

4. Active Infections

Serious infections should be evaluated before and during chemotherapy.

5. Pregnancy

Chlorambucil can cause fetal harm. Pregnancy should be avoided during treatment, and specialist reproductive counseling is essential.

6. Breastfeeding

Breastfeeding is not recommended during chlorambucil treatment because of the potential for serious adverse effects in the infant.

7. Fertility

Chlorambucil may cause temporary or permanent infertility.

Fertility preservation options should be discussed before treatment when appropriate.

8. Liver Disease

Patients with significant liver impairment may require dose modification and closer monitoring.

9. Kidney Disease

Renal function and overall clinical status should be considered during treatment planning.

10. Previous Chemotherapy

Previous cytotoxic treatment may increase the risk of cumulative bone marrow toxicity.

11. Previous Radiation Therapy

Prior radiation exposure may affect bone marrow reserve and treatment tolerance.

12. Seizure Disorders

Patients with a history of seizures require careful assessment because chlorambucil has been associated with neurological toxicity.

13. Live Vaccines

Live vaccines may be unsafe during significant chemotherapy-related immunosuppression.

14. Drug Interactions

The oncology team should review all medicines, especially:

  • Other cytotoxic chemotherapy medicines
  • Immunosuppressive medicines
  • Medicines that suppress bone marrow function
  • Certain live vaccines
  • Other treatments that increase infection or bleeding risk

15. Secondary Cancer Risk

Long-term or cumulative chlorambucil exposure can increase the risk of treatment-related malignancies.

16. Cytotoxic Handling

Chlorambucil tablets require appropriate handling precautions.

Pregnant individuals should avoid handling damaged tablets or powder from broken tablets.

17. Treatment Monitoring

Blood counts and clinical response must be reviewed throughout therapy.

18. Medical Monitoring

Healthcare professionals may assess:

  • Complete blood count
  • White blood cell count
  • Neutrophil count
  • Hemoglobin
  • Cumulative drug exposure
  • Fertility considerations
  • Pregnancy status when applicable
  • Drug interactions
  • Need for dose interruption
  • Long-term treatment complications

Potential Therapeutic Characteristics

  • Alkylating Antineoplastic Activity.
  • DNA Cross-Link Formation.
  • Interference With DNA Replication.
  • Established Nitrogen Mustard Derivative.
  • Use in Selected Hematological Malignancies.
  • Laboratory-Guided Treatment Monitoring.

Disadvantages / Limitations

  • Severe Bone Marrow Suppression Risk.
  • Increased Infection Risk.
  • Thrombocytopenia.
  • Anemia.
  • Bleeding Complications.
  • Nausea.
  • Rare Pulmonary Toxicity.
  • Delayed Blood Count Suppression.
  • Requires Frequent Laboratory Monitoring.
  • Requires Oncology Supervision.
  • Not Suitable for Self-Medication.
  • Not Preferred for Every Leukemia or Lymphoma.
  • Cytotoxic Handling Precautions Required.

Important Notes

Brand Name: Celkeran.

Generic Name: Chlorambucil.

Strength: 5 mg.

Drug Class: Alkylating Antineoplastic Agent.

Therapeutic Category: Oncology / Anticancer Medicine.

Mechanism of Action: DNA Alkylation and Cross-Link Formation.

Route: Oral.

Primary Applications: Selected Leukemias and Lymphomas.

Dosage: Oncology Specialist-Directed.

Major Warning: Severe Bone Marrow Suppression.

Infection Risk: Increased.

Bleeding Risk: Increased.

Secondary Cancer Risk: Present.

Fertility Risk: Potentially Serious or Permanent.

Pregnancy: Can Cause Fetal Harm.

Breastfeeding: Not Recommended During Treatment.

Monitoring: Regular Complete Blood Counts.

Handling: Cytotoxic Medicine Precautions.

Storage: Follow the Exact Manufacturer’s Label.

Frequently Asked Questions

1. What is Celkeran 5 mg used for?

Celkeran 5 mg is described as containing chlorambucil, an alkylating chemotherapy medicine used in selected leukemias and lymphomas.

2. Is Celkeran 5 mg a chemotherapy medicine?

Yes. Chlorambucil is a cytotoxic anticancer medicine belonging to the alkylating agent class.

3. How does chlorambucil work?

Chlorambucil damages DNA by forming chemical bonds and cross-links that interfere with DNA replication and cell division.

4. Can chlorambucil treat chronic lymphocytic leukemia?

Chlorambucil has established historical use in CLL, although newer therapies are preferred for many patients.

5. Can chlorambucil treat lymphoma?

It has been used for selected lymphoma types, but treatment suitability depends on the specific diagnosis and current oncology guidelines.

6. Is Celkeran 5 mg taken daily?

Some chlorambucil regimens use daily dosing, while others use intermittent schedules. The oncology specialist determines the correct regimen.

7. Can Celkeran 5 mg be taken without a prescription?

No. Chlorambucil is a prescription cytotoxic medicine that requires oncology supervision.

Product DetailsInformation
Product NameCelkeran 5 mg
Brand NameCelkeran
Generic NameChlorambucil
Active IngredientChlorambucil
Strength5 mg
Dosage FormOral Tablet – Verify Product Packaging
Drug ClassAlkylating Antineoplastic Agent
Therapeutic CategoryOncology / Anticancer Medicines
Primary UsesSelected Leukemias and Lymphomas
Mechanism of ActionDNA Alkylation and Cross-Link Formation
Route of AdministrationOral
Dosage FrequencyAccording to Oncology Prescription
Treatment DurationDepends on Cancer Type and Treatment Protocol
ManufacturerVerify Original Packaging
Pack SizeVerify Original Packaging
Prescription StatusPrescription-Only Cytotoxic Medicine
StorageFollow Manufacturer-Specific Labeling
Medical SupervisionRequired by an Oncology Specialist
Pack sizes30 tablets, 60 tablets, 90 tablets
Bulk / B2B price inquiry

Tell us what you need and we’ll reply by email.